CNR Institutional Research Information System

CASULA, MILENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.237
NA - Nord America 1.008
EU - Europa 720
SA - Sud America 376
AF - Africa 36
OC - Oceania 4
Totale 4.381
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 950
SG - Singapore 923
CN - Cina 492
BR - Brasile 306
IT - Italia 264
HK - Hong Kong 236
VN - Vietnam 236
NL - Olanda 139
FR - Francia 122
JP - Giappone 107
KR - Corea 75
IN - India 44
DE - Germania 41
GB - Regno Unito 38
BD - Bangladesh 24
CA - Canada 24
AR - Argentina 23
FI - Finlandia 22
ID - Indonesia 17
AT - Austria 16
IL - Israele 15
MX - Messico 15
PL - Polonia 14
IE - Irlanda 12
IQ - Iraq 10
ZA - Sudafrica 10
CO - Colombia 9
EC - Ecuador 9
SA - Arabia Saudita 9
VE - Venezuela 9
TR - Turchia 8
UA - Ucraina 7
UY - Uruguay 7
PH - Filippine 6
UZ - Uzbekistan 6
EG - Egitto 5
ES - Italia 5
KE - Kenya 5
MA - Marocco 5
PK - Pakistan 5
RU - Federazione Russa 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
PE - Perù 4
TN - Tunisia 4
AL - Albania 3
AU - Australia 3
BO - Bolivia 3
CL - Cile 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
HU - Ungheria 3
JM - Giamaica 3
NP - Nepal 3
OM - Oman 3
SE - Svezia 3
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
CU - Cuba 2
DZ - Algeria 2
EE - Estonia 2
JO - Giordania 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
PT - Portogallo 2
PY - Paraguay 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
GE - Georgia 1
GF - Guiana Francese 1
HN - Honduras 1
HR - Croazia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MM - Myanmar 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RS - Serbia 1
TH - Thailandia 1
ZM - Zambia 1
Totale 4.381
Salva come PNG Salva come JPEG
Città #
Singapore 523
Santa Clara 266
Hong Kong 233
Hefei 170
San Jose 151
Beijing 101
Lauterbourg 98
Ho Chi Minh City 93
Tokyo 93
Seoul 74
Ashburn 68
Los Angeles 57
Hanoi 55
Dallas 54
São Paulo 39
Cavallino 29
Cagliari 23
San Gregorio di Catania 23
Amsterdam 19
New York 19
Genoa 18
Council Bluffs 16
Orem 14
Milan 13
Minamishinagawa 12
Rio de Janeiro 12
Vienna 12
Dublin 11
Helsinki 11
Buffalo 10
Da Nang 10
Frankfurt am Main 10
Warsaw 10
Düsseldorf 9
Guangzhou 9
Montreal 9
Naples 9
Chennai 8
Rome 8
Assemini 7
Hải Dương 7
Johannesburg 7
Manchester 7
Nuremberg 7
Seattle 7
Turku 7
Bengaluru 6
Jakarta 6
Montevideo 6
Mumbai 6
Phoenix 6
Porto Alegre 6
Tashkent 6
Bari 5
Biên Hòa 5
Brooklyn 5
Chicago 5
Curitiba 5
Denver 5
Dhaka 5
Haiphong 5
London 5
Maceió 5
Munich 5
Quận Một 5
Baghdad 4
Boston 4
Buenos Aires 4
Elk Grove Village 4
Florence 4
Houston 4
Lappeenranta 4
Las Vegas 4
Mexico City 4
Nairobi 4
Newark 4
Recife 4
Riyadh 4
Sala Baganza 4
Salvador 4
San Francisco 4
Sassari 4
Belo Horizonte 3
Boardman 3
Calgary 3
Campinas 3
Casablanca 3
Changsha 3
Falkenstein 3
Florianópolis 3
Franca 3
Goiânia 3
Guayaquil 3
Istanbul 3
Itapema 3
Jeddah 3
Kingston 3
Lima 3
Magé 3
Maricá 3
Totale 2.672
Salva come PNG Salva come JPEG
Nome #
Four years of activity of the Melanoma Unit of Sassari across North Sardinia 116
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 92
Progetto Alternanza scuola lavoro 2016 - Liceo Scientifico G.Marconi di Sassari 78
Il CSCC: aspetti distintivi della patologia 76
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 73
Liquid Biopsy in the Oncological Management of a Histologically Undiagnosed Lung Carcinoma: A Case Report 72
Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma 69
nalysis of Fanconi anemia genes in colorectal cancer. 65
Microsatellite instability in melanocytic skin lesions (benign nevi, dysplastic nevi, and primary melanomas along with their metastases) 64
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 63
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 63
Molecular landscape profile of melanoma 62
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 61
Genetic Instability Markers in Cancer 59
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 59
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 59
Liquid biopsy in clinical oncology 59
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 59
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 58
Mutational status of main oncogenes and microsatellite instability in Sardinian patients with advanced colorectal cancer 58
Genetic alterations in main candidate genes during melanoma progression. 56
KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research 54
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 52
Molecular classification of patients with malignant melanoma for new therapeutic strategies. 52
Different pathogenetic mechanisms are underlying molecular alterations in fanconi and mismatch DNA repair genes among patients with colorectal carcinoma 51
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma 51
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial 51
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 51
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 50
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 50
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 50
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 49
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21 48
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 48
Liquid biopsy-driven Cetuximab rechallenge strategy in molecularly selected metastatic colorectal cancer patients 48
Genetic alterations at chromosome 9p21 and melanoma progression. 47
The enigmatic role of TP53 in germ cell tumours: Are we missing something? 46
Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches 43
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 41
Four-year follow-up and re-treatment of mesothelioma patients with combined tremelimumab and durvalumab: the NIBIT-MESO-1 study 41
Disease progression and overall survival in Sardinian patients with colorectal cancer according to the kras mutational status 40
Complete and Durable Response to Combined Chemo/Radiation Therapy in EGFR Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases 40
Proteomic analysis in melanoma cell lines with different genotypes 39
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 38
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 38
Comparison of multiple tumor lesions from the same melanoma patients using next-generation sequencing (NGS) approaches 37
Primary Melanoma of the Lung: A Systematic Review 36
Analyses of key-regulator genes in melanoma susceptibility and pathogenesis among patients from south Italy. 35
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: A population-based study 35
Genetic alterations at chromosome 9p21 in primary tumors and metastases from patients with sporadic melanoma: Definition of their clinical significance 34
Search for therapeutic response molecular markers in malignant melanoma through NGS: on the way to an anti-BRAF combination therapy. 34
Identification of candidate transcripts at chromosomes 10q25-q26 and 9p21 in endometrial cancer (EC) and malignant melanoma (MM). 33
WNT/β-catenin signaling is modulated by mechanical ventilation in an experimental model of acute lung injury 32
Female Adnexal Tumors of probable Wolffian Origin (FATWO): a case series with next-generation sequencing mutation analysis 32
A novel candidate gene in human endometrial cancer at chromosome 10q26 32
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma 32
DEFINITION OF THE ROLE OF CHROMOSOME 9P21 IN SPORADIC MELANOMA THROUGH GENETIC ANALYSIS OF PRIMARY TUMORS AND THEIR METASTASES 31
Low prevalence of microsatellite instability in malignant melanoma. 30
Molecular classification for the management of melanoma patients. 30
Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy 30
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 30
Mechanical ventilation modulates TLR4 and IRAK-3 in a non-infectious, ventilator-induced lung injury model 30
Genetic alterations in main candidate genes during melanoma progression 30
Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. 29
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 29
Low levels of genetic heterogeneity in matched lymph node metastases from melanoma patients 29
Evaluation of genetic heterogeneity in paired lymph node metastases from melanoma patients using next-generation sequencing (NGS) approaches 29
Mechanical ventilation modulates Toll-like receptor signaling pathway in a sepsis-induced lung injury model 29
Fanconi genes may contribute to melanoma pathogenesis. 28
Identification of predictive factors for the occurrence of predisposing MLH1 and MSH2 germline mutations among Sardinian patients with colorectal carcinoma 28
Pattern and distribution of BRAF/NRAS and P16CDKN2A mutations among primary an secondary lesions in melanoma patients [abstract]. 28
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 28
Sequential accumulation of molecular alterations at the chromosome 9p21 during development and progression of melanoma. 27
Germline mutations in candidate genes among patients with cutaneous melanoma from Sardinia. 27
Multiple molecular pathways in melanomagenesis: Characterization of therapeutic targets 27
A pattern of polymorphic variants at the CDKN2 locus is associated with both susceptibility and prognosis in melanoma patients. 26
The susceptibility CDKN2 locus may have a role on prognosis of melanoma patients 26
The EGF 61A>G polymorphism has no role in nevi formation and melanoma pathogenesis within italian population 26
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup study 26
Mutation analysis of candidate genes in familial cases with malignant melanoma: identification of an additional susceptibility region at chromosome 9p21 26
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 26
Molecular alterations at chromosome 9p21 in melanocytic nevi and melanoma. 26
Toward the characterization of a genetic profile with prognostic value at CDKN2A locus in melanoma patients. 25
Mutational analysis of candidate genes in families with malignant melanoma (MM): assessment of the role of the CDKN2A gene in MM predisposition. 25
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy 25
Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign nevi, dysplastic nevi, and primary melanomas along with their metastases. 25
Downregulation of the CASC2a gene in endometrial cancer. 25
Epidemiological and genetic factors underlying melanoma development in Italy 24
Identification of a novel candidate gene, MENC, in a consensus region of allelic deletion at chromosome 10q26 in human endometrial cancer. 24
Serial RT-PCR detection of circulating tumour cells as a marker of disease progression in patients with malignant melanoma. 24
Mutational analysis of candidate genes among patients with malignant melanoma from south Italy. 24
Role on the BRAF gene in malignant melanoma 24
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland 24
Fanconi genes are altered in subsets of patients with sporadic colorectal carcinoma. 23
Cytogenetic assesment of the involvement of a new locus at 9p21 in malignant melanoma. 23
Progressive alterations at chromosome 9P21 in melanomagenesis 23
Role of CASC2 a gene in human endometrial cancer. 23
Genetic and epigenetic alterations of mismatch repair genes in endometrial and colorectal carcinomas 23
Distribution of the BRCA2-8765delAG mutation in breast cancer in mediterranean area. 23
Mutation analysis of HMLH1-HMSH2 genes among Sardinian patients with sporadic and familial colorectal cancer 23
Totale 4.072
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.277
article - articoli 10.600
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 546
Totale 25.423
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202415 0 0 0 0 0 0 0 0 2 0 9 4
2024/20251.721 14 6 100 51 280 111 51 101 66 143 410 388
2025/20262.803 147 226 266 337 466 144 455 199 220 233 110 0
Totale 4.539